Latest Regulatory Pathways News

Island Pharmaceuticals has strengthened its intellectual property portfolio with a Singapore patent covering ISLA-101 for flavivirus infections, including Dengue and Chikungunya, extending commercial exclusivity to 2034 in a key Asia-Pacific market.

Prodigy Gold is progressing key regulatory approvals to restart mining at its Old Pirate gold mine, supported by encouraging ore sorting testwork that significantly upgrades gold grades and promises operational efficiencies.

Memphasys has locked in a three-year exclusive distribution agreement for its Felix™ sperm separation system in Thailand, targeting a key IVF market with 110 clinics and 20,000–30,000 cycles annually. The deal adds approximately A$430,500 in contracted revenue, lifting South-East Asian minimum contracts to about A$1 million and contributing to FY2026 Felix™ sales now exceeding A$3 million.

Native Mineral Resources (ASX:NMR) has cleared a key regulatory hurdle by submitting a Progressive Rehabilitation and Closure Plan for its Far Fanning Gold Project, while maintaining steady gold production at its Blackjack Gold Mine.

Akora Resources has completed a $3.3 million equity raise combining a $1.6 million placement and a modest $187,000 entitlement offer, positioning the company to push forward with mine development following its recent mining permit grant.

The Calmer Co. has won Coles' approval for its innovative Fiji Kava® FZZR™ product, extending its Australian supermarket reach while gearing up for a broader U.S. retail rollout supported by a key brokerage partnership.

Western Australia's State Government has backed VRX Silica's land swap proposal at Muchea, unlocking access to a significantly larger high-grade silica sand resource with lower environmental impact and paving the way for downstream glass manufacturing.

CONNEQT Health has lodged an FDA Pre-Submission for SphygmoCor Cloud, aiming to shift its arterial health analytics from hardware to a scalable software platform with broad commercial potential.

Jindalee Lithium’s US subsidiary, HiTech Minerals, has partnered with environmental nonprofit RESOLVE to investigate a voluntary stewardship area around its McDermitt Lithium Project, aiming to balance responsible lithium development with conservation efforts.

Island Pharmaceuticals has presented encouraging Phase 2a results for its dengue antiviral ISLA-101, demonstrating safety, effective blood concentrations, and meaningful viral load reductions at the Asia Dengue Summit.

CLINUVEL Pharmaceuticals has lodged its Form 20-F with the U.S. SEC, seeking to elevate its American Depository Receipt program to a Nasdaq-listed American Depository Share, aiming to boost visibility and liquidity without raising capital.

Encounter Resources is aggressively advancing its Aileron niobium project in Western Australia with a comprehensive 70,000-metre drilling campaign and a Mining Lease application, underpinning its push toward development.